Abstract
Background
Cervical lymph node metastasis is a vital factor associated with local recurrence in papillary thyroid carcinoma (PTC). Tumor size is used in the staging of PTC because it represents the tumor load. This study compared two methods of tumor size assessment to predict tumor behavior in the relationship between size and cervical node involvement for patients with PTC.
Methods
The study enrolled 1084 patients who underwent initial thyroid surgery and had a pathologic diagnosis of PTC between 2012 and 2014 at The Second Affiliated Hospital Zhejiang University School of Medicine. Cervical lymph node metastasis (LNM) risk was analyzed according to the clinicopathologic features. For each patient with multifocal disease, two tumor size estimates were used: (1) the dominant focus size and (2) the aggregate size, calculated as the sum of the maximal diameters of all tumor foci.
Results
Of the 1084 patients, 294 (27.1%) had multifocal cancer lesions, and 49% of these patients had cervical LNM, compared with 38.1% who had unifocal disease (P = 0.001). The use of aggregate dimension significantly increased the tumor size and reclassified significant numbers of multifocal PTCs to a more advanced T stage. This aggregate dimension took account of all tumor foci and predicted LNM risk at a proportion identical with that for size-matched, unifocal tumors.
Conclusion
Multifocality together with aggregate tumor size is a more accurate predictor of node status and, by inference, tumor behavior in the relationship between tumor size and cervical node involvement.
Similar content being viewed by others
References
Pisanu A, Reccia I, Nardello O, Uccheddu A. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg. 2009;33:460–68.
Moreno MA, Agarwal G, de Luna R, Siegel ER, Sherman SI, Edeiken-Monroe BS, et al. Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2011;137:157–62.
Amdur RJ, Mazzaferri EL. The American Joing Committee on Cancer system of staging thyroid cancer. In: Amdur RJ, Mazzaferri EL, eds. Essentials of Thyroid Cancer Management. New York: Springer-Verlag Inc; 2005. p. 33–6.
Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X, et al. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol. 2013;20:746–52.
Crippa S, Mazzucchelli L, Cibas ES, Ali SZ. The Bethesda System for reporting thyroid fine-needle aspiration specimens. Am J Clin Pathol. 2010;134:343–4.
DeLelis R, Lloyd R, Heitz P, Eng C. Pathology and genetics of tumours of endocrine organs. Lyon: WHO Classification of Tumours. IARC Press; 2004.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014; 12:1495–99.
Acknowledgment
This study was supported by the Clinical Study Foundation of Zhejiang Province, China (2013ZYC-A20).
Disclosure
The authors have nothing to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ping Wang and Yong Wang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, P., Wang, Y., Miao, C. et al. Defining a New Tumor Dimension in Staging of Papillary Thyroid Carcinoma. Ann Surg Oncol 24, 1551–1556 (2017). https://doi.org/10.1245/s10434-017-5764-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-017-5764-z